 | • レポートコード：MRC2304L210 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、254ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年に6,682.30百万ドルであった世界のインスリンポンプ市場規模が、2022年に7,397.03百万ドルへと拡大し、その後CAGR 10.87％で成長して2027年までに12,413.08百万ドルに達すると予測しています。当書は、インスリンポンプの世界市場を総合的に分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（インスリンポンプ用品＆付属品、インスリンポンプ）分析、疾患別（1型糖尿病、2型糖尿病）分析、付属品別（輸液セット挿入器具、輸液セット、インスリンリザーバー）分析、流通チャネル別（病院薬局、小売薬局）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目をまとめています。なお、当書に掲載されている企業情報には、Abbott Laboratories、Animas Corporation、Bayer AG、Cellnovo Group SA.、Cigna Corporation、Dexcom Inc.、F. Hoffmann-La Roche Ltd.、Insulet Corporation、Jiangsu Delfu Co. Ltd、Medtronic、Merck KGaA、MicroPort Scientific Corporationなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のインスリンポンプ市場規模：製品別 - インスリンポンプ用品＆付属品の市場規模 - インスリンポンプの市場規模 ・世界のインスリンポンプ市場規模：疾患別 - 1型糖尿病における市場規模 - 2型糖尿病における市場規模 ・世界のインスリンポンプ市場規模：付属品別 - 輸液セット挿入器具の市場規模 - 輸液セットの市場規模 - インスリンリザーバーの市場規模 ・世界のインスリンポンプ市場規模：流通チャネル別 - 病院薬局チャネルの市場規模 - 小売薬局チャネルの市場規模 ・世界のインスリンポンプ市場規模：地域別 - 南北アメリカのインスリンポンプ市場規模 アメリカのインスリンポンプ市場規模 カナダのインスリンポンプ市場規模 ブラジルのインスリンポンプ市場規模 ... - アジア太平洋のインスリンポンプ市場規模 日本のインスリンポンプ市場規模 中国のインスリンポンプ市場規模 インドのインスリンポンプ市場規模 韓国のインスリンポンプ市場規模 台湾のインスリンポンプ市場規模 ... - ヨーロッパ/中東/アフリカのインスリンポンプ市場規模 イギリスのインスリンポンプ市場規模 ドイツのインスリンポンプ市場規模 フランスのインスリンポンプ市場規模 ロシアのインスリンポンプ市場規模 ... - その他地域のインスリンポンプ市場規模 ・競争状況 ・企業情報 |
The Global Insulin Pumps Market size was estimated at USD 6,682.30 million in 2021 and expected to reach USD 7,397.03 million in 2022, and is projected to grow at a CAGR 10.87% to reach USD 12,413.08 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Insulin Pumps to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Insulin Pump Supplies & Accessories and Insulin Pumps.
Based on Disease Indication, the market was studied across Type 1 Diabetes and Type 2 Diabetes.
Based on Accessories, the market was studied across Infusion Set Insertion Devices, Infusion Sets, and Insulin Reservoirs.
Based on Distribution Channel, the market was studied across Hospital Pharmacy, Retail Pharmacy, and Sales and Diabetes.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Insulin Pumps market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Insulin Pumps Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Insulin Pumps Market, including Abbott Laboratories, Animas Corporation, Bayer AG, Cellnovo Group SA., Cigna Corporation, Dexcom Inc., F. Hoffmann-La Roche Ltd., Insulet Corporation, Jiangsu Delfu Co. Ltd, Medtronic, Merck KGaA, MicroPort Scientific Corporation, Roche Diagnostics Corporation, Sanofi SA, Sensonic Corporation, SOOIL Developments Co., Tandem Diabetes Care, Inc., Terumo Corporation, Valeritas, Inc., and Ypsomed AG.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Insulin Pumps Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Insulin Pumps Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Insulin Pumps Market?
4. What is the competitive strategic window for opportunities in the Global Insulin Pumps Market?
5. What are the technology trends and regulatory frameworks in the Global Insulin Pumps Market?
6. What is the market share of the leading vendors in the Global Insulin Pumps Market?
7. What modes and strategic moves are considered suitable for entering the Global Insulin Pumps Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Expanding geriatic population have expanded the need for personalized medicine
5.1.1.2. Increasing healthcare funding and government initiatives to promote diabetes awareness
5.1.1.3. Growing awareness towards efficient diabetes management with insulin delivery devices
5.1.2. Restraints
5.1.2.1. Lack of skilled professional for appropriate handling of insulin pump
5.1.2.2. Risk of skin infection or allergic reaction and patient suffering from ketoacidosis
5.1.3. Opportunities
5.1.3.1. Advent of artificial intelligence in diabetes care devices
5.1.3.2. Rising initiatives taken by the government
5.1.4. Challenges
5.1.4.1. High cost of insulin devices
5.2. Cumulative Impact of COVID-19
6. Insulin Pumps Market, by Product
6.1. Introduction
6.2. Insulin Pump Supplies & Accessories
6.3. Insulin Pumps
7. Insulin Pumps Market, by Disease Indication
7.1. Introduction
7.2. Type 1 Diabetes
7.3. Type 2 Diabetes
8. Insulin Pumps Market, by Accessories
8.1. Introduction
8.2. Infusion Set Insertion Devices
8.3. Infusion Sets
8.4. Insulin Reservoirs
9. Insulin Pumps Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Retail Pharmacy
9.4. Sales and Diabetes
10. Americas Insulin Pumps Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Insulin Pumps Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Insulin Pumps Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abbott Laboratories
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Animas Corporation
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Bayer AG
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Cellnovo Group SA.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Cigna Corporation
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Dexcom Inc.
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. F. Hoffmann-La Roche Ltd.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Insulet Corporation
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Jiangsu Delfu Co. Ltd
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Medtronic
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Merck KGaA
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. MicroPort Scientific Corporation
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Roche Diagnostics Corporation
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Sanofi SA
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Sensonic Corporation
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. SOOIL Developments Co.
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Tandem Diabetes Care, Inc.
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Terumo Corporation
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Valeritas, Inc.
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Ypsomed AG
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing